On April 29, the U.S. Food and Drug Administration authorized Zevaskyn, a first-of-its-kind gene therapy for recessive dystrophic epidermolysis bullosa (RDEB), a devastating genetic condition causing fragile, blistering skin. Developed by Abeona Therapeutics, the therapy represents a major milestone for rare disease patients but also underscores the escalating costs of biotech breakthroughs—a trend critics argue…

Putin announces three-day ceasefire in Ukraine for Victory Day, raising skepticism and hope Russian President Vladimir Putin announced a three-day ceasefire in Ukraine, starting on May 8 and ending on May 10, coinciding with Russia's Victory Day celebrations. The ceasefire follows intense pressure from U.S. President Donald J. Trump, who has called for a cessation…

There’s no question that obesity is terrible for health. And one of the worst impacts it has is on cancer risk. Obesity is linked to an increased risk of more than a dozen types of cancer, and it’s also shown to worsen prognosis and survival rates. The metabolic changes and chronic inflammation associated with obesity…

Moderna faces suspension from the U.K. pharmaceutical trade body (ABPI) after multiple violations, including unethical incentives (cash and gifts) for child vaccine trial participation, banned under U.K. law. Despite being alerted by campaigners in August 2023, Moderna executives ignored violations until the Health Research Authority intervened in January 2024, revealing a lack of transparency and…